[Demyelinating encephalomyelitis associated with treatment with adalimumab]

Neurologia. 2010 Mar;25(2):136-8.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Anti-Inflammatory Agents / adverse effects*
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Demyelinating Diseases* / chemically induced
  • Demyelinating Diseases* / pathology
  • Encephalomyelitis* / chemically induced
  • Encephalomyelitis* / pathology
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Adalimumab